Publications

2022

  1. Volfovitch Y., Tsur A. M., Gurevitch M. et_al. (2022) Immunologic Research. 70, 6, p. 817-828  Abstract
  2. Salaroglio I. C., Belisario D. C., Akman M. et_al. (2022) Journal Of Experimental & Clinical Cancer Research. 41, 1, 243.  Abstract

2018

  1. Salaroglio I. C., Gazzano E., Abdullrahman A. et_al. (2018) Journal Of Experimental & Clinical Cancer Research. 37, 286.  Abstract
  2. Kopecka J., Salaroglio I. C., Righi L. et_al. (2018) Lung Cancer. 120, p. 34-45  Abstract
  3. Rubinstein M. (2018) The journal of Biological chemistry. 293, 1, p. 112-112  Abstract
  4. Rubinstein M. & Dvash E. (2018) Current Opinion in Nephrology and Hypertension. 27, 1, p. 42-48  Abstract

2017

  1. Salaroglio I. C., Panada E., Moiso E., Buondonno I., Provero P., Rubinstein M., Kopecka J. & Riganti C. (2017) Molecular Cancer. 16, 1, 91.  Abstract
  2. Wassermann Dozorets D. R. & Rubinstein M. (2017) Cell Death & Disease. 8, 2733.  Abstract

2016

  1. Dvash E. & Rubinstein M. (2016) Cell cycle (Georgetown, Tex.). 15, 7, p. 869-70 26890977.  Abstract

2015

  1. Dvash E., Har-Tal M., Barak S., Meir O. & Rubinstein M. (2015) Nature Communications. 6, 10112.  Abstract
  2. Riganti C., Kopecka J., Panada E., Barak S. & Rubinstein M. (2015) JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE. 107, 5,  Abstract

2014

  1. Garin-Shkolnik T., Rudich A., Hotamisligil G. S. & Rubinstein M. (2014) Diabetes. 63, 3, p. 900-911  Abstract

2013

  1. Finkelshtein D., Werman A., Novick D., Barak S. & Rubinstein M. (2013) Proceedings of the National Academy of Sciences of the United States of America. 110, 18, p. 7306-7311  Abstract

2012

  1. Shechter Y., Sasson K., Lev Goldman G. V., Rubinraut S., Rubinstein M. & Fridkin M. (2012) Bioconjugate Chemistry. 23, 8, p. 1577-1586  Abstract

2011

  1. Novick D. & Rubinstein M. (2011) Cytokine Protocols. Ley M.(eds.). p. 195-214  Abstract
  2. Zhang W., Lin M., Winesett A. et_al. (2011) Polymers for Advanced Technologies. 22, 1, p. 65-71  Abstract

2010

  1. Novick D., Elbirt D., Miller G., Dinarello C. A., Rubinstein M. & Sthoeger Z. M. (2010) Journal of Autoimmunity. 34, 2, p. 121-126  Abstract
  2. Meir O., Dvash E., Werman A. & Rubinstein M. (2010) PLoS ONE. 5, 3, e9516.  Abstract

2009

  1. Novick D., Elbirt D., Dinarello C. A., Rubinstein M. & Sthoeger Z. M. (2009) Journal of Clinical Immunology. 29, 1, p. 38-45  Abstract

2008

  1. Werman A., Alkahe B., Dinarello C. A. & Rubinstein M. (2008) Cytokine. 43, 3, p. 307-307  Abstract
  2. Werman A., Korba B. E., Alkahe B., Finkelshtein D., Bujanover S., Novick D., Vinocour E. & Rubinstein M. (2008) Cytokine. 43, 3, p. 249-249  Abstract

2007

  1. Thompson S. R., Novick D., Stock C. J. et_al. (2007) ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY. 27, 12, p. 2743-2749  Abstract
  2. Rubinstein M. (2007) Cytokine & Growth Factor Reviews. 18, 5-6, p. 519-524  Abstract
  3. Spiegel A., Shivtiel S., Kalinkovich A. et_al. (2007) Nature Immunology. 8, 10, p. 1123-1131  Abstract
  4. Naftali T., Novick D., Gabay G., Rubinstein M. & Novis B. (2007) Israel Medical Association Journal. 9, 7, p. 504-508  Abstract
  5. Hurgin V., Novick D., Werman A., Dinarello C. A. & Rubinstein M. (2007) Cytokine. 39, 1, p. 17-17  Abstract
  6. Thompson S. R., Novick D., Stock C., Rubinstein M., Woo P., Humphries S. E. & Sanders J. (2007) Atherosclerosis Supplements. 8, 1, p. 52-52  Abstract
  7. Birk R. Z. & Rubinstein M. (2007) Biochemical and Biophysical Research Communications. 355, 3, p. 626-631  Abstract
  8. Hurgin V., Novick D., Werman A., Dinarello C. A. & Rubinstein M. (2007) Proceedings of the National Academy of Sciences of the United States of America. 104, 12, p. 5044-5049  Abstract
  9. Novick D. & Rubinstein M. (2007) Cytokine & Growth Factor Reviews. 18, 5-6, p. 525-533  Abstract

2006

  1. Birk R. & Rubinstein M. (2006) Biochemical and Biophysical Research Communications. 345, 2, p. 669-674  Abstract
  2. Novick D., Rubinstein M., Azam T., Rabinkov A., Dinarello C. & Kim S. (2006) Proceedings of the National Academy of Sciences of the United States of America. 103, 9, p. 3316-3321  Abstract

2005

  1. Neumayr G., Ludwiczek O., Hoertnagl H., Pfister R., Mitterbauer C., Moschen A., Novick D., Rubinstein M. & Tilg H. (2005) International Journal of Sports Medicine. 26, 10, p. 836-840  Abstract
  2. Mazodier K., Marin V., Novick D. et_al. (2005) Blood. 106, 10, p. 3483-3489  Abstract
  3. Shechter Y., Tsubery H., Mironchik M., Rubinstein M. & Fridkin M. (2005) FEBS Letters. 579, 11, p. 2439-2444  Abstract
  4. Barkan D., Hurgin V., Dekel N., Amsterdam A. & Rubinstein M. (2005) FASEB Journal. 19, 1, p. 133-135  Abstract
  5. Elevated systemic levels of free interleukin-18 (IL-18) in patients with Crohn's disease
    Ludwiczek O., Kaser A., Novick D., Dinarello C., Rubinstein M. & Tilg H. (2005) European Cytokine Network. 16, 1, p. 27-33  Abstract

2004

  1. Gutman G., Har-Toov J., Many A., Lessing J., Novick D., Rubinstein M. & Jaffa A. (2004) American Journal of Obstetrics and Gynecology. 191, 6, p. S152-S152  Abstract
  2. Erratum: Molecular defects of the growth hormone receptor gene, including a new mutation, in Laron syndrome patients in Israel: Relationship between defects and ethnic groups (The Israel Medical Association Journal (632))
    Shevah O., Rubinstein M. & Laron Z. (2004) Israel Medical Association Journal. 6, 11, p. 717  Abstract
  3. Kawashima M., Novick D., Rubinstein M. & Miossec P. (2004) Arthritis and Rheumatism. 50, 6, p. 1800-1805  Abstract
  4. Shevah O., Galli-Tsinopoulou A., Rubinstein M., Nousia-Arvanitakis S. & Laron Z. (2004) Journal Of Pediatric Endocrinology & Metabolism. 17, 3, p. 371-374  Abstract

2003

  1. Azam T., Novick D., Bufler P., Yoon D., Rubinstein M., Dinarello C. & Kim S. (2003) Journal of Immunology. 171, 12, p. 6574-6580  Abstract
  2. Lonnemann G., Novick D., Rubinstein M. & Dinarello C. (2003) Clinical Nephrology. 60, 5, p. 327-334  Abstract
  3. Feezor R., Oberholzer C., Baker H. et_al. (2003) Infection and Immunity. 71, 10, p. 5803-5813  Abstract
  4. Shevah O., Borrelli P., Rubinstein M. & Laron Z. (2003) Journal of Endocrinological Investigation. 26, 7, p. 604-608  Abstract
  5. Gangemi S., Basile G., Merendino R. et_al. (2003) Experimental Gerontology. 38, 6, p. 669-672  Abstract
  6. Dinarello C., Novick D., Rubinstein M. & Lonnemann G. (2003) Blood Purification. 21, 3, p. 258-270  Abstract
  7. Stuyt R., Kim S., Reznikov L. et_al. (2003) Cytokine. 21, 2, p. 65-73  Abstract
  8. Lonnemann G., Novick D., Rubinstein M., Passlick-Deetjen J., Lang D. & Dinarello C. (2003) Blood Purification. 21, 3, p. 225-231  Abstract
  9. Nolsoe R., Pociot F., Novick D., Rubinstein M., Kim S., Dinarello C. & Mandrup-Poulsen T. (2003) Immunology Of Diabetes Ii: Pathogenesis From Mouse To Man. 1005, p. 332-339  Abstract

2002

  1. Hurgin V., Novick D. & Rubinstein M. (2002) Proceedings of the National Academy of Sciences of the United States of America. 99, 26, p. 16957-16962  Abstract
  2. Ludwiczek O., Kaser A., Novick D., Dinarello C., Rubinstein M., Vogel W. & Tilg H. (2002) Journal of Clinical Immunology. 22, 6, p. 331-337  Abstract
  3. Sandowski Y., Raver N., Gussakovsky E., Shochat S., Dym O., Livnah O., Rubinstein M., Krishna R. & Gertler A. (2002) Journal of Biological Chemistry. 277, 48, p. 46304-46309  Abstract
  4. IL-12 and IL-18 induce MAP kinase-dependent adhesion of T cells to extracellular matrix components
    Ariel A., Novick D., Rubinstein M., Dinarello C., Lider O. & Hershkoviz R. (2002) Journal of Leukocyte Biology. 72, 1, p. 192-198  Abstract
  5. Kim S., Azam T., Novick D., Yoon D., Reznikov L., Bufler P., Rubinstein M. & Dinarello C. (2002) Journal of Biological Chemistry. 277, 13, p. 10998-11003  Abstract
  6. Kaser A., Novick D., Rubinstein M. et_al. (2002) Clinical and Experimental Immunology. 129, 2, p. 332-338  Abstract
  7. Yatsiv I., Morganti-Kossmann M., Perez D. et_al. (2002) Journal of Cerebral Blood Flow and Metabolism. 22, 8, p. 971-978  Abstract
  8. Shevah O., Nunez O., Rubinstein M. & Laron Z. (2002) Journal Of Pediatric Endocrinology & Metabolism. 15, 7, p. 1039-1040  Abstract

2001

  1. Almog B., Gold R., Tajima K. et_al. (2001) Molecular and Cellular Endocrinology. 183, 1-2, p. 179-191  Abstract
  2. Novick D., Schwartsburd B., Pinkus R. et_al. (2001) Cytokine. 14, 6, p. 334-342  Abstract
  3. Arazi T., Slutsky S., Shiboleth Y., Wang Y., Rubinstein M., Barak S., Yang J. & Gal-On A. (2001) Journal of Biotechnology. 87, 1, p. 67-82  Abstract
  4. Kim S., Azam T., Yoon D., Reznikov L., Novick D., Rubinstein M. & Dinarello C. (2001) Proceedings of the National Academy of Sciences of the United States of America. 98, 6, p. 3304-3309  Abstract
  5. Cohen B., Barkan D., Levy Y., Goldberg I., Fridman E., Kopolovic J. & Rubinstein M. (2001) Journal of Biological Chemistry. 276, 11, p. 7697-7700  Abstract
  6. Stuyt R., Netea M., Kim S., Novick D., Rubinstein M., Kullberg B., Van der Meer d. M. J. & Dinarello C. (2001) Infection and Immunity. 69, 8, p. 5025-5030  Abstract
  7. Zecchina G., Novick D., Rubinstein M., Barak V., Dinarello C. & Nagler A. (2001) Journal of Hematotherapy and Stem Cell Research. 10, 6, p. 769-776  Abstract

2000

  1. Kim S., Eisenstein M., Reznikov L., Fantuzzi G., Novick D., Rubinstein M. & Dinarello C. (2000) Proceedings of the National Academy of Sciences of the United States of America. 97, 3, p. 1190-1195  Abstract
  2. Reznikov L., Kim S., Westcott J., Frishman J., Fantuzzi G., Novick D., Rubinstein M. & Dinarello C. (2000) Proceedings of the National Academy of Sciences of the United States of America. 97, 5, p. 2174-2179  Abstract
  3. Vidal-Vanaclocha F., Fantuzzi G., Mendoza L. et_al. (2000) Proceedings of the National Academy of Sciences of the United States of America. 97, 2, p. 734-739  Abstract
  4. Harvesting the human genome: The Israeli perspective
    Ben-Asher E., Chalifa-Caspi V., Horn-Saban S. et_al. (2000) Israel Medical Association Journal. 2, 9, p. 657-664  Abstract
  5. Novick D., Nabioullin R., Ragsdale W. et_al. (2000) Journal of Interferon and Cytokine Research. 20, 11, p. 971-982  Abstract
  6. Liu B., Novick D., Kim S. & Rubinstein M. (2000) Cytokine. 12, 10, p. 1519-1525  Abstract

1999

  1. Barkan D., Jia H., Dantes A., Vardimon L., Amsterdam A. & Rubinstein M. (1999) Endocrinology. 140, 4, p. 1731-1738  Abstract
  2. Novick D., Kim S., Fantuzzi G., Reznikov L., Dinarello C. & Rubinstein M. (1999) Immunity. 10, 1, p. 127-136  Abstract

1998

  1. Zelzer E., Levy Y., Kahana C., Shilo B., Rubinstein M. & Cohen B. (1998) EMBO Journal. 17, 17, p. 5085-5094  Abstract
  2. Dinarello C., Novick D., Puren A. et_al. (1998) Journal of Leukocyte Biology. 63, 6, p. 658-664  Abstract
  3. Rubinstein M., Dinarello C., Oppenheim J. & Hertzog P. (1998) Cytokine & Growth Factor Reviews. 9, 2, p. 175-181  Abstract

1997

  1. Kim S., Cohen B., Novick D. & Rubinstein M. (1997) Gene. 196, 1-2, p. 279-286  Abstract
  2. Mechanism(s) of interferon inhibitory activity in blood from patients with aids and patients with lupus erythematosus with vasculitis
    Ambrus J. L., Ambrus J. L., Chadha S., Novick D., Rubinstein M., Gopalakrishnan B., Bernstein Z., Priore R. L. & Chadha K. C. (1997) Research Communications in Molecular Pathology and Pharmacology. 96, 3, p. 255-265  Abstract

1996

  1. Cohen B., Novick D. & Rubinstein M. (1996) Science. 274, 5290, p. 1185-1188  Abstract
  2. Gamus D., Romano A., Rubinstein M. & Savion N. (1996) Experimental Eye Research. 63, 1, p. 1-7  Abstract

1995

  1. Domanski P., Witte M., Kellum M., Rubinstein M., Hackett R., Pitha P. & Colamonici O. R. (1995) Journal of Biological Chemistry. 270, 37, p. 21606-21611  Abstract
  2. LIGAND-INDUCED ASSOCIATION OF THE TYPE-I INTERFERON RECEPTOR COMPONENTS
    Cohen B., Novick D., Barak S. & Rubinstein M. (1995) Molecular and Cellular Biology. 15, 8, p. 4208-4214  Abstract
  3. Novick D., Cohen B., Tal N. & Rubinstein M. (1995) Journal of Leukocyte Biology. 57, 5, p. 712-718  Abstract

1994

  1. FISCHER D., Novick D., Cohen B. & Rubinstein M. (1994) Proceedings Of The Society For Experimental Biology And Medicine. 206, 3, p. 228-232  Abstract
  2. The secreted tumor-associated antigen 90K is a potent immune stimulator
    Ullrich A., Sures I., D'Egidio M. et_al. (1994) Journal of Biological Chemistry. 269, 28, p. 18401-18407  Abstract
  3. Novick D., Cohen B. & Rubinstein M. (1994) Cell. 77, 3, p. 391-400  Abstract

1993

  1. FISCHER D., Tal N., Novick D., Barak S. & Rubinstein M. (1993) Science. 262, 5131, p. 250-253  Abstract
  2. Rubinstein M. (1993) Bio/Technology. 11, 4, p. 420  Abstract

1992

  1. EDELBAUM O., STEIN D., HOLLAND N., GAFNI Y., Livneh O., Novick D., Rubinstein M. & Sela I. (1992) Journal of Interferon Research. 12, 6, p. 449-453  Abstract
  2. Novick D., Cohen B. & Rubinstein M. (1992) FEBS Letters. 314, 3, p. 445-448  Abstract
  3. Reiter Z., Loyter A., Nussbaum O. & Rubinstein M. (1992) Cellular Immunology. 142, 2, p. 370-384  Abstract
  4. Interleukin-6 protects ductal breast carcinoma cells from MHC-unrestricted cell-mediated cytotoxicity
    Reiter Z., Chen L., Revel M. & Rubinstein M. (1992) Lymphokine and Cytokine Research. 11, 3, p. 175-181  Abstract

1991

  1. Merimsky O., Rubinstein M., Fischer D., Danon A. & Chaitchik S. (1991) Cancer Chemotherapy and Pharmacology. 27, 5, p. 406-408  Abstract
  2. RESISTANCE TO NK-CELL-MEDIATED CYTOTOXICITY (IN K-562 CELLS) DOES NOT CORRELATE WITH CLASS-I MHC ANTIGEN LEVELS
    REITER Z., REITER Y., FISHELSON Z., SHINITZKY M., KESSLER A., LOYTER A., NUSSBAUM O. & Rubinstein M. (1991) Immunobiology. 183, 2-Jan, p. 23-39  Abstract
  3. EDELBAUM O., SHER N., Rubinstein M., Novick D., Tal N., MOYER M., WARD E., RYALS J. & Sela I. (1991) Plant Molecular Biology. 17, 1, p. 171-173  Abstract
  4. Yonish-Rouach E., Kimchi A. & Rubinstein M. (1991) Transplantation. 51, 6, p. 1276-1282  Abstract
  5. Yonish-Rouach E., Fischer D. G. & Rubinstein M. (1991) Cellular Immunology. 134, 2, p. 402-413  Abstract
  6. PRODUCTION, DOWNSTREAM PROCESSING AND CHARACTERIZATION OF PROTEINS FROM RECOMBINANT ANIMAL-CELLS - THE CASE OF HUMAN INTERFERON-BETA
    Rubinstein M., Revel M., Novick D. et_al. (1991) Biologicals From Recombinant Microorganisms And Animal Cells: Production And Recovery. p. 479-486  Abstract
  7. Novick D., Engelmann H., Revel M., Leitner O. & Rubinstein M. (1991) Hybridoma. 10, 1, p. 137-146  Abstract

1990

  1. YONISHROUACH E., SHINITZKY M. & Rubinstein M. (1990) Journal of Immunological Methods. 135, 1-2, p. 147-153  Abstract
  2. LAZARD D., Tal N., Rubinstein M., Khen M., Lancet D. & ZUPKO K. (1990) Biochemistry. 29, 32, p. 7433-7440  Abstract
  3. Novick D., ENGELMANN H., Wallach D., Leitner O., Revel M. & Rubinstein M. (1990) Journal of Chromatography A. 510, C, p. 331-337  Abstract
  4. Reiter Z. & Rubinstein M. (1990) Cellular Immunology. 125, 2, p. 326-336  Abstract
  5. MECHANISMS INVOLVED IN REGULATION OF THE RESPONSE TO TUMOR-NECROSIS-FACTOR - POSSIBLE ROLES FOR PROSTAGLANDIN PRODUCTION IN SENSITIZATION TO TNF EFFECTS AND FOR A SPECIFIC TNF-BINDING PROTEIN IN PROTECTION FROM THEM
    Wallach D., ADERKA D., Rubinstein M., ENGELMANN H., AVNI Y., SAROV I. & HOLTMANN H. (1990) Tumor Necrosis Factor : Structure, Mechanism Of Action, Role In Disease And Therapy. p. 146-155  Abstract
  6. SOLUBLE CYTOKINE-RECEPTORS ARE PRESENT IN NORMAL HUMAN URINE
    Novick D., ENGELMANN H., Wallach D. & Rubinstein M. (1990) Physiological And Pathological Effects Of Cytokines. 10, p. 413-421  Abstract
  7. SOLUBLE FORMS OF THE TNF RECEPTORS, PURIFIED FROM HUMAN URINE, INHIBIT TNF EFFECTS - ANTIBODIES AGAINST THE SOLUBLE RECEPTORS INDUCE TNF-LIKE EFFECTS
    ENGELMANN H., ADERKA D., HOLTMANN H. et_al. (1990) Molecular And Cellular Biology Of Cytokines. 10, p. 299-308  Abstract
  8. Two antiviral proteins from tobacco: Purification and characterization by monoclonal antibodies to human β-interferon
    EDELBAUM O., ILAN N., GRAFI G., SHER N., STRAM Y., Novick D., Tal N., Sela I. & Rubinstein M. (1990) Proceedings of the National Academy of Sciences of the United States of America. 87, 2, p. 588-592  Abstract

1989

  1. Revel M., ZILBERSTEIN A., CHEN L., GOTHELF Y., BARASH I., Novick D., Rubinstein M. & MICHALEVICZ R. (1989) Annals of the New York Academy of Sciences. 557, 1, p. 144-156  Abstract
  2. Novick D., Engelmann H., Wallach D. & Rubinstein M. (1989) Journal of Experimental Medicine. 170, 4, p. 1409-1414  Abstract
  3. BIOLOGICAL-ACTIVITIES OF RECOMBINANT HUMAN IFN-BETA-2/IL-6 (ESCHERICHIA-COLI)
    Revel M., ZILBERSTEIN A., CHEN L., GOTHELF Y., BARASH I., Novick D., Rubinstein M. & MICHALEVICZ R. (1989) Regulation Of The Acute Phase And Immune Responses : Interleukin-6. 557, p. 144-156  Abstract
  4. A tumor necrosis factor-binding protein purified to homogeneity from human urine protects cells from tumor necrosis factor toxicity
    ENGELMANN H., ADERKA D., Rubinstein M., ROTMAN D. & Wallach D. (1989) Journal of Biological Chemistry. 264, 20, p. 11974-11980  Abstract
  5. Mechanisms which take part in regulation of the response to tumor necrosis factor
    Wallach D., Holtmann H., Aderka D., Rubinstein M., Avni Y. S., Sarov I. & Engelman H. (1989) Lymphokine Research. 8, 3, p. 359-363  Abstract

1988

  1. Chen L., Novick D., Rubinstein M. & Revel M. (1988) FEBS Letters. 239, 2, p. 299-304  Abstract
  2. Reiter Z., Fischer D. G. & Rubinstein M. (1988) Immunology Letters. 17, 4, p. 323-328  Abstract
  3. Shabo Y., Lotem J., Rubinstein M., Revel M., Clark S. C., Wolf S. F., Kamen R. & Sachs L. (1988) Blood. 72, 6, p. 2070-2073  Abstract

1987

  1. Revel M., Zilberstein A., Ruggieri R. M., Rubinstein M. & Chen L. (1987) Journal of Interferon Research. 7, 5, p. 529-536  Abstract
  2. Rubinstein M. (1987) Journal of Interferon Research. 7, 5, p. 545-551  Abstract
  3. The human interferon-gamma receptor. Purification, characterization, and preparation of antibodies
    Novick D., ORCHANSKY P., Revel M. & Rubinstein M. (1987) Journal of Biological Chemistry. 262, 18, p. 8483-8487  Abstract

1986

  1. Goren T., Fischer D. G. & Rubinstein M. (1986) Journal of Interferon Research. 6, 4, p. 323-329  Abstract
  2. Mizrachi Y., Rubinstein M., KIMHI Y. & Schwartz M. (1986) Journal of Neurochemistry. 46, 6, p. 1675-1682  Abstract
  3. MORY Y., BENBARAK J., SEGEV D. et_al. (1986) DNA. 5, 3, p. 181-193  Abstract
  4. Goren T., FISCHER D. & Rubinstein M. (1986) Biochimica Et Biophysica Acta. 887, 1, p. 80-85  Abstract
  5. Fischer D. G. & Rubinstein M. (1986) Immunobiology. 172, 1-2, p. 110-119  Abstract
  6. Rubinstein M., Orchansky P. & Zoon K. C. (1986) Critical Reviews in Biochemistry and Molecular Biology. 21, 3, p. 249-275  Abstract
  7. The interferon-γ receptor in human monocytes is different from the one in nonhematopoietic cells
    Orchansky P., Rubinstein M. & Fischer D. G. (1986) Journal of Immunology. 136, 1, p. 169-173  Abstract

1985

  1. ROSENBERG H., MADAR Z., GERTLER A., Rubinstein M. & BINO T. (1985) Journal of Interferon Research. 5, 1, p. 121-127  Abstract

1984

  1. CHERNAJOVSKY Y., MORY Y., CHEN L., MARKS Z., Novick D., Rubinstein M. & Revel M. (1984) DNA. 3, 4, p. 297-308  Abstract
  2. Friedlander J., Fischer D. G. & Rubinstein M. (1984) Analytical Biochemistry. 137, 1, p. 115-119  Abstract
  3. Finel M., Rubinstein M. & Pick U. (1984) FEBS Letters. 166, 1, p. 85-89  Abstract

1983

  1. Goren T., Kapitkovsky A., Kimchi A. & Rubinstein M. (1983) Virology. 130, 2, p. 273-280  Abstract
  2. Fischer D. G. & Rubinstein M. (1983) Cellular Immunology. 81, 2, p. 426-434  Abstract
  3. Novick D., Eshhar Z., FISCHER D., FRIEDLANDER J. & Rubinstein M. (1983) The EMBO Journal. 2, 9, p. 1527-1530  Abstract
  4. Novick D., Eshhar Z., Gigi O., Marks Z., Revel M. & Rubinstein M. (1983) Unknown Journal. 64, 4, p. 905-910  Abstract

1982

  1. Rubinstein M. (1982) Biochimica et Biophysica Acta - Reviews on Cancer. 695, 1, p. 5-16  Abstract
  2. Fellous M., NIR U., Wallach D., MERLIN G., Rubinstein M. & Revel M. (1982) Proceedings Of The National Academy Of Sciences Of The United States Of America-Biological Sciences. 79, 10 I, p. 3082-3086  Abstract
  3. Rubinstein M. (1982) PHILOSOPHICAL TRANSACTIONS OF THE ROYAL SOCIETY OF LONDON SERIES B-BIOLOGICAL SCIENCES. 299, 1094, p. 39-50  Abstract
  4. Monoclonal antibodies to human α-interferon and their use for affinity chromatography
    Novick D., Eshhar Z. & Rubinstein M. (1982) Journal of Immunology. 129, 5, p. 2244-2247  Abstract
  5. Orchansky P., Rubinstein M. & Sela I. (1982) Proceedings Of The National Academy Of Sciences Of The United States Of America-Biological Sciences. 79, 7 I, p. 2278-2280  Abstract

1977

  1. Shechter Y., Rubinstein M. & Patchornik A. (1977) Biochemistry. 16, 7, p. 1424-1430  Abstract

1976

  1. Rubinstein M., Shechter Y. & Patchornik A. (1976) Biochemical and Biophysical Research Communications. 70, 4, p. 1257-1263  Abstract

1975

  1. Shechter Y., Rubinstein M., BECKER R. & BOHAK Z. (1975) European Journal of Biochemistry. 58, 1, p. 123-131  Abstract
  2. Rubinstein M., Amit B. & Patchornik A. (1975) Tetrahedron Letters. 16, 17, p. 1445-1448  Abstract
  3. Rubinstein M. & Patchornik A. (1975) Tetrahedron. 31, 17, p. 2107-2110  Abstract
  4. Rubinstein M. & Patchornik A. (1975) Tetrahedron. 31, 13-14, p. 1517-1519  Abstract